Florida could buy monoclonal antibody directly from GlaxoSmithKline, governor Ron DeSantis said, between the turmoil and Biden’s supervisors over a similar supply of drugs from Regeneron.
DeSantis said Thursday he had spoken to officials from GSK and that Florida could “order” the amount of the company’s monoclonal antibody. “We’ll do this if we can,” he added.
The government last month set up a site to develop anti-monoclonal antibodies and mobile units, one of the ways to try to prevent people living with coronavirus from developing the dangerous symptoms that need medical attention.
The Department of Health and Human Services recently changed the way they distribute monoclonal antibodies after Joe Biden promised the government would increase shipping by 50 percent. White House press secretary Jen Psaki said on Thursday the government would provide Regeneron’s assistance “would not be unlimited, and we believe it should be done equally in all countries.” Seven countries, including Florida, have 70% of orders, according to Psaki.
However, as a result of these changes, shipments to Florida have remained he fell to the hospital 30,950 each week from 72,000, according to Christina Pushaw, a spokeswoman for DeSantis.
The governor, speaking at a hospital in Fort Lauderdale, said Florida could use its own method of obtaining GSK monoclonal antibody, called sotrovimab, “to address any shortcomings”.
“We’ve been thrown a ball here and a big cut from HHS by Biden’s management,” DeSantis said.
Reports have shown that the number of people killed by Covid-19 in Florida has dropped in recent weeks, a sign encouraging the advent of the Delta virus. Officials said on Thursday the total number of Covid-19 patients in the hospital dropped for 24 consecutive days.